Verovir Pharma SA
Verovir Pharma reported total assets of €1.02m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026).
The score of Verovir Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +8 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 20 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Verovir Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Verovir Pharma's financial analysis
- Solvency98.8%sector median: 66.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Verovir Pharma
Verovir Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0452.353.263
- VAT number
- BE0452353263
- Peppol
- Registered · 0208:0452353263 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 31 Mar 1994
- Registered office
- 6032 Charleroi
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Other monetary intermediation (NACE 64190)
Verovir Pharma (SA) has been based in Charleroi since 1994, active in: other monetary intermediation. For 2025, it reports a net profit of 49,471 € and equity of €1.01m; its revenue is not published. Its solvency stands at 98.8%, above the median of its sector (66.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Verovir Pharma
Companies in the same business, of comparable size and area, outside its group.
- Drogo Alessandro Finances Other monetary intermediation Ath · balance sheet €1.08m
- Archles Finances Other monetary intermediation Saint-Gilles · balance sheet 932,057 €
- BV Service Other monetary intermediation Poperinge · balance sheet 833,699 €
- Kantoor Vandewoude Other monetary intermediation Diksmuide · balance sheet €1.38m
- DY Invest Other monetary intermediation Evere · balance sheet 659,337 €
- dRF Finances Other monetary intermediation Anderlecht · balance sheet 510,736 €
- Pyrova Other monetary intermediation Oud-Heverlee · balance sheet 447,685 €
- Belkremas Other monetary intermediation Nijlen · balance sheet 413,932 €
Frequently asked questions about Verovir Pharma
What is the revenue of Verovir Pharma?
Verovir Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Verovir Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0452353263 for Verovir Pharma, if the company is VAT-registered. Its company number (CBE) is 0452.353.263.
Where is the registered office of Verovir Pharma?
According to the CBE register, the registered office of Verovir Pharma is in 6032 Charleroi.
What is the equity of Verovir Pharma?
At the close of the 2025 financial year, the equity of Verovir Pharma amounts to 1,005,132 €, a solvency of 98.8% of total assets.
Who manages Verovir Pharma?
The register lists 1 active mandates at Verovir Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Verovir Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →